Company: LGN
Filing Date: 2025-04-30
Form Type: DRS/A
Source: 0000950123-25-003868
Chunk: 0

Company: Legence Corp.
Filing Date: 2025-04-30
Form: DRS/A
Chunk 0
---
Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83 AS CONFIDENTIALLY SUBMITTED TO THE U.S. SECURITIES AND EXCHANGE COMMISSION ON APRIL 29, 2025. This draft registration statement has not been filed, publicly or otherwise, with the U.S. Securities and Exchange Commission and all information contained herein remains strictly confidential. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Confidential Draft Submission No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Legence Corp. (Exact name of registrant as specified in its charter)

| Delaware                        |     |                         1711 |     | 33-2905250         |
| (State or other jurisdiction of 
 incorporation or organization)  |     | -Primary Standard Industrial 
   Classification Code Number |     | -I.R.S. Employer   
 Identification No. |

1601 Las Plumas Avenue San Jose, CA 95133 (833) 534-3623 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Jeffrey Sprau Chief Executive Officer 1601 Las Plumas Avenue San Jose, CA 95133 (833) 534-3623 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to:

| Matthew R. Pacey, P.C.      
 Michael W. Rigdon, P.C.     
 Billy Vranish               
 Kirkland & Ellis LLP        
 609 Main Street, Suite 4700 
 Houston, TX 77002           
 (713)                       
 836-3600                    |     | Byron B. Rooney               
 Roshni Banker Cariello        
 Davis Polk & Wardwell LLP     
 450 Lexington Avenue New      
 York, NY 10017 (212) 450-4000 |

Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: ☐ If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement